The Ministry of Health in the UAE has given a marketing’s permit for a new drug for diabetes patients in the country. This disease is one of the most common diseases in the country with about a million diabetes patient and a possibility of other 900 thousand to have it as well.
The new drug “Jardaince” is being manufactured by the German company Boehringer Ingelheim, the drug is dedicated to treat diabetes patients type 2. The company has proven its efficiency fighting heart diseases and blood vessels, which are the main leading causes to death for 52% of diabetes patients around the world, according to the statistics of the World Health Organization.
The WHO statistics has also revealed that diabetes causes the death of about 3.2 million people a year around the world, and that the Middle East Area recorded at least one death out of 4 cases among adults aged between 35 and 64.
A new study by the Food and Drug Administration on about 7,000 debates adults, has proven that this drug helped reducing deaths to 32% of caused by cardiovascular diseases, compared to 38% of deaths from all other causes.
The price of the new drug in the UAE is 260 Dirhams for a month supply of 10 mg, and 310 Dirhams of the 25 mg.